Evidence map›Paper›PMID 41311373›Full record

ArticleBiochemistry and biophysics reports2025

HECTD1-mediated SFTPB overexpression in fibrotic lung induced by silica.

Mengling Chen, Shencun Fang

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mengling ChenDepartment of Respiratory Medicine, Nanjing Chest Hospital, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
Shencun FangDepartment of Respiratory Medicine, Nanjing Chest Hospital, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alveolar epithelial cells type 2 are lung progenitor and secretory cells capable of secreting four surfactant proteins, namely surfactant protein A (SFTPA), surfactant protein B (SFTPB), surfactant protein C (SFTPC), and surfactant protein D (SFTPD). Among these proteins, SFTPB not only participates in the composition of surfactant proteins but also has important immune functions. In occupational dust exposure, dust entering the bronchi and alveoli can come into direct contact and stimulate AT2. To investigate the expression of SFTPB in fibrotic lungs, we constructed a mouse pulmonary fibrosis model using silica and detected the spatial expression of SFTPB protein and SFTPB mRNA in lung sections. Herein, we observed an increase in SFTPB production from AT2 in SiO

Indexed as

Alveolar epithelial cell type 2HECT domain E3 ubiquitin protein ligase 1Lung fibrosisSurfactant protein B

Identifiers

PMID41311373
PMCPMC12648099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.